Antibiotic Resistance, Biofilm Formation, and Intracellular Survival As Possible Determinants of Persistent or Recurrent Infections by


Journal

Microbial drug resistance (Larchmont, N.Y.)
ISSN: 1931-8448
Titre abrégé: Microb Drug Resist
Pays: United States
ID NLM: 9508567

Informations de publication

Date de publication:
Jun 2020
Historique:
pubmed: 12 12 2019
medline: 7 4 2021
entrez: 12 12 2019
Statut: ppublish

Résumé

Resistance is notoriously high in Asia but may not entirely explain therapeutic failures. Specific modes of bacterial life, such as biofilm or intracellular survival, may also contribute to the persistent and/or recurrent character of infections. Most

Identifiants

pubmed: 31825276
doi: 10.1089/mdr.2019.0282
doi:

Substances chimiques

Anti-Bacterial Agents 0
DNA-Binding Proteins 0
Moxifloxacin U188XYD42P

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

537-544

Auteurs

Tiep Khac Nguyen (TK)

Pharmacologie Cellulaire et Moléculaire, Louvain Drug Research Institute, Université Catholique de Louvain (UCLouvain), Brussels, Belgium.

Maria A Argudín (MA)

Centre National de Référence des Staphylocoques, Laboratoire Hospitalier Universitaire de Bruxelles (LHUB-ULB) Site Anderlecht, Hôpital Erasme-Cliniques Universitaires de Bruxelles, Université Libre de Bruxelles, Brussels, Belgium.

Ariane Deplano (A)

Centre National de Référence des Staphylocoques, Laboratoire Hospitalier Universitaire de Bruxelles (LHUB-ULB) Site Anderlecht, Hôpital Erasme-Cliniques Universitaires de Bruxelles, Université Libre de Bruxelles, Brussels, Belgium.

Pham Hong Nhung (PH)

Department of Microbiology, Bach Mai Hospital, Hanoi, Vietnam.

Hoang Anh Nguyen (HA)

The National Center for Drug Information and Adverse Drug Reactions Monitoring, Hanoi University of Pharmacy, Hanoi, Vietnam.

Paul M Tulkens (PM)

Pharmacologie Cellulaire et Moléculaire, Louvain Drug Research Institute, Université Catholique de Louvain (UCLouvain), Brussels, Belgium.

Magali Dodemont (M)

Centre National de Référence des Staphylocoques, Laboratoire Hospitalier Universitaire de Bruxelles (LHUB-ULB) Site Anderlecht, Hôpital Erasme-Cliniques Universitaires de Bruxelles, Université Libre de Bruxelles, Brussels, Belgium.

Françoise Van Bambeke (F)

Pharmacologie Cellulaire et Moléculaire, Louvain Drug Research Institute, Université Catholique de Louvain (UCLouvain), Brussels, Belgium.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH